Aryna Sabalenka Makes History by Defending US Open Title; IM8 Experiences Rapid Growth with Viral Marketing Campaign

Aryna Sabalenka defends her US Open title, marking historic achievement for women's tennis and IM8 brand engagement.

Quiver AI Summary

Aryna Sabalenka made history by becoming the first woman to defend her US Open title since 2014, marking her second consecutive championship victory at the prestigious tournament. Her success is particularly significant for Prenetics Global Limited and its supplement brand IM8, as Sabalenka is both a global ambassador and the first current athlete shareholder. Since launching in December 2024, IM8 has rapidly gained traction, achieving over 300,000 customer purchases and delivering more than 6 million servings. This growth was further enhanced by a viral AI-powered advertisement featuring Sabalenka, which garnered 233 million views on Instagram. Throughout her winning season, Sabalenka has credited her performance and health improvements in part to using IM8's products, which are NSF Certified for Sport. Prenetics CEO Danny Yeung expressed pride in Sabalenka's achievements, emphasizing her impact on the brand and the integrity of their products.

Potential Positives

Aryna Sabalenka's historic achievement of defending her US Open title enhances the visibility and credibility of Prenetics and its IM8 brand, showcasing the effectiveness of their product through a world-class athlete.
The IM8 brand achieved significant growth with over 300,000 customer purchases and more than 6 million servings delivered within just 9 months of its launch, indicating strong market acceptance and consumer trust.
The viral AI-powered advertisement featuring Aryna Sabalenka, which garnered over 233 million views and displayed on Times Square, boosts brand recognition and engagement for IM8, aligning it with high-profile marketing efforts.
Aryna Sabalenka's endorsement of IM8 Daily Ultimate Essentials, an NSF Certified product for athletes, lends prestigious validation to the supplement, reinforcing its safety and quality in a competitive market.

Potential Negatives

While IM8 has achieved 300,000 customer purchases, the press release does not provide information on profit margins or financial sustainability, which could raise concerns about the long-term viability of the brand despite early success.
The announcement heavily relies on the success of Aryna Sabalenka, creating a potential risk for the company if her performance or public image were to decline in the future.
The press release mentions significant marketing efforts, but does not address the potential for high marketing costs to impact overall profitability, which could be a concern for investors.

FAQ

Who won the 2025 US Open women's singles title?

Aryna Sabalenka won the 2025 US Open women's singles title, making history by defending her title.

What is IM8's connection to Aryna Sabalenka?

Aryna Sabalenka is not only a global ambassador for IM8 but also its first current athlete shareholder.

How successful has IM8 been since its launch?

Since launching in December 2024, IM8 has achieved over 300,000 customer purchases and over 6 million servings delivered.

What is IM8 Daily Ultimate Essentials?

IM8 Daily Ultimate Essentials is a comprehensive supplement that replaces 16 individual supplements and provides 92 essential nutrients.

How has Aryna Sabalenka promoted IM8?

Aryna's recent AI-powered advertisement for IM8 went viral on Instagram, amassing over 233 million views.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$PRE Hedge Fund Activity

We have seen 4 institutional investors add shares of $PRE stock to their portfolio, and 4 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BLACKROCK, INC. added 24,822 shares (+inf%) to their portfolio in Q2 2025, for an estimated $211,359
UBS GROUP AG removed 20,605 shares (-75.1%) from their portfolio in Q2 2025, for an estimated $175,451
STEVENS CAPITAL PARTNERS added 17,382 shares (+inf%) to their portfolio in Q2 2025, for an estimated $148,007
QUINN OPPORTUNITY PARTNERS LLC removed 12,339 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $105,066
NOMURA HOLDINGS INC removed 11,703 shares (-3.5%) from their portfolio in Q2 2025, for an estimated $99,651
MORGAN STANLEY added 6,800 shares (+320.2%) to their portfolio in Q2 2025, for an estimated $57,902
SBI SECURITIES CO., LTD. removed 56 shares (-98.2%) from their portfolio in Q2 2025, for an estimated $476

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release

Aryna Sabalenka becomes first woman to defend US Open title in more than a decade
AI-powered Aryna Sabalenka ad goes viral with 233M Instagram views and Times Square billboard during US Open
IM8 achieves 300,000+ customer purchases and 6 million servings in just 9 months since launch

CHARLOTTE, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, and its premium supplement brand IM8, co-founded by David Beckham, today extends heartfelt congratulations to global ambassador and shareholder, World No. 1 tennis player Aryna Sabalenka, on successfully defending her singles championship at the 2025 US Open.

This historic achievement marks an extraordinary moment for Prenetics and IM8, as their flagship athlete ambassador has claimed victory at one of the most prestigious tournaments in tennis for the second consecutive year. Aryna Sabalenka became the first woman to defend her US Open title since Serena Williams in 2014 and now owns four Grand Slam trophies. Aryna Sabalenka, who began using IM8 Daily Ultimate Essentials earlier this year and became the company's first-ever current athlete shareholder, has showcased exceptional resilience, determination, and peak performance, embodying the very spirit of the IM8 brand.

Since launching in December 2024, IM8 has experienced explosive growth, with over 300,000 customer purchases and more than 6 million servings delivered, demonstrating exceptional consumer confidence and product satisfaction. The brand's momentum has been further amplified by a recent AI-powered advertisement featuring Aryna Sabalenka that has gone viral on Instagram, garnering over 233 million views since August 25th. The campaign has also been prominently displayed on Times Square's massive billboards throughout the US Open and will continue running through September.

"I am thrilled to have defended my US Open title," said Aryna Sabalenka. "This victory is the result of immense hard work from my entire team. A huge part of my success is my focus on my health and recovery, and IM8 Daily Ultimate Essentials has been an essential part of my daily routine."

Danny Yeung, CEO and Co-Founder of Prenetics and IM8, expressed his excitement: "We are incredibly proud of Aryna for her phenomenal victory at the US Open and for successfully defending her title. Having the World No. 1 not only as our global ambassador but also as our first current athlete shareholder makes this achievement even more meaningful. Her success validates everything we've built at IM8, and we are honored to support her journey to excellence."

Aryna Sabalenka, who recently became a shareholder in Prenetics and global ambassador for IM8, has had a dominant season, culminating in her second consecutive US Open singles title. Her journey with IM8 began when her performance coach, Jason Stacy, recommended the supplement. After experiencing significant benefits for over three months, Aryna Sabalenka’s team proactively reached out and culminated in a multi-year partnership with IM8.

IM8 Daily Ultimate Essentials is a comprehensive all-in-one supplement that replaces 16 individual supplements, providing 92 essential nutrients including vitamins, minerals, probiotics, and clinical dosages of CoQ10 and MSM in a delicious drink. Crucially for professional athletes, IM8 is NSF Certified for Sport, ensuring it is free from banned substances and meets the highest standards of quality and safety required by elite competitors.

About Prenetics Global Limited
Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer health. Our consumer initiative is led by IM8, a fast-growing health and wellness brand, Europa, one of the largest sports distribution companies in the USA, and CircleDNA, a leading direct-to-consumer DNA test. As the first healthcare company to establish a Bitcoin treasury with its initial $20 million Bitcoin purchase and board-approved comprehensive Bitcoin strategy, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption. To learn more please visit prenetics.com and IM8health.com

About IM8
IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8’s flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a 100% owned subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company dedicated to advancing consumer health.

Media Contact:

Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited
[email protected]

Danielle Mulholland
Jack Taylor Public Relations
[email protected]